Executive Summary
PolyPeptide relocated and expanded its Innovation Lab in Strasbourg A focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and manufacturing of synthetic peptides and
The city of Strasbourg, nestled in the Grand Est region of northeastern France, is home to a pivotal facility for PolyPeptide, a globally recognized leader in the development and manufacturing of synthetic peptides. PolyPeptide France Strasbourg, located at 7 rue de Boulogne, 67100 Strasbourg, stands as a testament to the company's commitment to excellence and innovation within the pharmaceutical sector.
PolyPeptide Labs has established itself as a world leader, specializing in custom peptide synthesis and the production of both proprietary and generic GMP-grade peptides. The Strasbourg site plays a crucial role within the PolyPeptide Group, a focused Contract Development & Manufacturing Organization (CDMO). This designation highlights their expertise in providing comprehensive services to the pharmaceutical and biotechnology industries, from early-stage development through to commercial-scale manufacturing.
The Strasbourg facility is equipped to handle a wide range of peptide manufacturing needs. It manufactures proprietary research scale peptides at milligram to gram scale, alongside bioactive peptides and non-natural amino acids. This capability allows them to support diverse research and development projects, catering to precise client specifications. The site is an integral part of PPL Laboratories, the collective name for PolyPeptide's global network of facilities.
With over 170 dedicated employees, the PolyPeptide France site in Strasbourg is a significant contributor to the company's global operations. The company emphasizes INNOVATION - We are curious and explore new ways and EXCELLENCE - We have a strong technical knowledge and we deliver results. This ethos is embodied in their continuous efforts to advance peptide synthesis technologies and manufacturing processes. A prime example of this commitment is the recent relocation and expansion of their PolyPeptide Innovation Lab in Strasbourg-Illkirch, underscoring their dedication to cutting-edge research and development.
PolyPeptide's presence in Strasbourg is not just about manufacturing; it's about fostering a culture of scientific advancement. The company actively recruits talent, with opportunities in areas such as Global Head of Engineering & Automation Governance Engineering and various technical roles, contributing to its reputation for offering PolyPeptide careers and PolyPeptide jobs in Strasbourg. Their commitment to quality is reflected in their adherence to Good Manufacturing Practices (GMP), ensuring the highest standards for all manufactured products.
The Strasbourg location, situated within the TECHNOPOLE DU RHIN 7 RUE DE BOULOGNE 67100 STRASBOURG, benefits from its strategic position in a region known for its scientific and industrial prowess. PolyPeptide Laboratories France SAS operates with a capital of EUR 9,000,000 and is registered with the RCS Strasbourg under the SIRET number 414 477 695. The company’s dedication to client success and its robust manufacturing capabilities solidify its position as a key player in the peptide synthesis landscape, both in France and on the international stage. Their comprehensive approach as a CDMO ensures that clients receive reliable, high-quality peptide solutions tailored to their specific therapeutic or research objectives.
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
